Applied Therapeutics is a biopharmaceutical company dedicated to creating transformative treatments to address high unmet need rare diseases.
Applied Therapeutics is led by an experienced team united by a commitment to develop urgently needed treatments for patients with high unmet medical need.
Applied Therapeutics leverages technological advances to target molecules and pathways with proven roles in disease biology, new FDA guidance for the use of biomarkers, as well as established clinical endpoints, to bring products to market. This approach can accelerate time from clinical development to approval, and into the hands of patients who urgently need treatment.